share_log
Reuters ·  Mar 31 10:47
Luye Pharma - Rivastigmine Twice Weekly Transdermal Patch- Approved for Marketing in Japan
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 384

Recommended

Write a comment